SOX2 and colorectal cancer: The administration of AP or P or AP + P as therapy or prophylaxis in PHZ-induced colorectal cancer significantly downregulated the colonic mRNA expression of CK-20, SOX-2, OCT-4, and NanoG compared to the PHZ group (Figure 8A–D).